Abstract
Imeglimin (PXL008, EMD-387008, Twymeeg & REG;) is a first-in-class novel oral hypoglycemic agent, launched in Japan, for the treatment of type 2 d......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
